447 related articles for article (PubMed ID: 23060474)
1. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
Pinsky PF; Berg CD
J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
[TBL] [Abstract][Full Text] [Related]
2. Improving selection criteria for lung cancer screening. The potential role of emphysema.
Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
[TBL] [Abstract][Full Text] [Related]
3. Annual number of lung cancer deaths potentially avertable by screening in the United States.
Ma J; Ward EM; Smith R; Jemal A
Cancer; 2013 Apr; 119(7):1381-5. PubMed ID: 23440730
[TBL] [Abstract][Full Text] [Related]
4. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
6. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
7. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
[TBL] [Abstract][Full Text] [Related]
8. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
[TBL] [Abstract][Full Text] [Related]
9. The performance of NLST screening criteria in Asian lung cancer patients.
Kumar V; Becker K; Zheng HX; Huang Y; Xu Y
BMC Cancer; 2015 Nov; 15():916. PubMed ID: 26582178
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
11. Application of risk prediction models to lung cancer screening: a review.
Tammemägi MC
J Thorac Imaging; 2015 Mar; 30(2):88-100. PubMed ID: 25692785
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
Tanner NT; Dai L; Bade BC; Gebregziabher M; Silvestri GA
Am J Respir Crit Care Med; 2017 Sep; 196(5):602-608. PubMed ID: 28722466
[TBL] [Abstract][Full Text] [Related]
13. Baseline characteristics of participants in the randomized national lung screening trial.
; Aberle DR; Adams AM; Berg CD; Clapp JD; Clingan KL; Gareen IF; Lynch DA; Marcus PM; Pinsky PF
J Natl Cancer Inst; 2010 Dec; 102(23):1771-9. PubMed ID: 21119104
[TBL] [Abstract][Full Text] [Related]
14. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.
Howard DH; Richards TB; Bach PB; Kegler MC; Berg CJ
Cancer; 2015 Dec; 121(24):4341-7. PubMed ID: 26372542
[TBL] [Abstract][Full Text] [Related]
15. Evaluating efficacy of current lung cancer screening guidelines.
Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
[TBL] [Abstract][Full Text] [Related]
16. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
17. The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST.
Yip R; Henschke CI; Yankelevitz DF; Boffetta P; Smith JP;
Eur J Cancer Prev; 2015 May; 24(3):201-8. PubMed ID: 25089376
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer screening.
Arenberg D
Semin Respir Crit Care Med; 2013 Dec; 34(6):727-37. PubMed ID: 24258563
[TBL] [Abstract][Full Text] [Related]
19. Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial.
Robertson SE; Joyce NR; Steingrimsson JA; Stuart EA; Aberle DR; Gatsonis CA; Dahabreh IJ
JAMA Netw Open; 2024 Jan; 7(1):e2346295. PubMed ID: 38289605
[TBL] [Abstract][Full Text] [Related]
20. Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations.
Callol L; Roig F; Cuevas A; de Granda JI; Villegas F; Jareño J; Arias E; Albiach JM
Lung Cancer; 2007 May; 56(2):217-21. PubMed ID: 17316889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
